Zobrazeno 1 - 10
of 5 539
pro vyhledávání: '"Neisseria meningitidis serogroup B"'
Autor:
Borrow R; Meningococcal Reference Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Martinón-Torres F; Pediatrics Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela, Galicia, Spain.; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Abitbol V; Global Medical Affairs Neisseria, GSK, Rueil-Malmaison, France., Andani A; Global Medical Affairs, GSK, Wavre, Belgium., Preiss S; Global Medical Affairs, GSK, Rockville, MD, USA., Muzzi A; Bacterial Computational Genomics, GSK, Siena, Italy., Serino L; Vaccine Development, GSK, Siena, Italy., Sohn WY; Global Medical Affairs, GSK, Rockville, MD, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2023 Jan-Dec; Vol. 22 (1), pp. 738-748.
Autor:
Zeevat, Florian1,2 (AUTHOR), Simons, Joost J. M.1,3,4 (AUTHOR) joost.j.simons@gsk.com, Westra, Tjalke A.3 (AUTHOR), Wilschut, Jan C.1 (AUTHOR), van Sorge, Nina M.5 (AUTHOR), Boersma, Cornelis1,2,6 (AUTHOR), Postma, Maarten J.1 (AUTHOR)
Publikováno v:
Infectious Diseases & Therapy. Mar2024, Vol. 13 Issue 3, p481-499. 19p.
Autor:
Florian Zeevat, Joost J. M. Simons, Tjalke A. Westra, Jan C. Wilschut, Nina M. van Sorge, Cornelis Boersma, Maarten J. Postma
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 481-499 (2024)
Abstract Introduction Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is a rapidly progressing, rare disease that often presents as meningitis or sepsis. It mostly affects infants and adolescents, with high fatality rates or lon
Externí odkaz:
https://doaj.org/article/e533bfc6adb84078b0470a511629ab13
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bettencourt C; National Reference Laboratory for Neisseria meningitidis, Department of Infectious Diseases, National Institute of Health (INSA), 1649-016 Lisbon, Portugal. Electronic address: celia.betencourt@insa.min-saude.pt., Nogueira P; Laboratório de Biomatemática - Instituto de Medicina Preventiva e Saúde Pública, 1649-028 Lisbon, Portugal. Electronic address: pnogueira@medicina.ulisboa.pt., Paulo Gomes J; Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health (INSA), 1649-016 Lisbon, Portugal. Electronic address: j.paulo.gomes@insa.min-saude.pt., João Simões M; National Reference Laboratory for Neisseria meningitidis, Department of Infectious Diseases, National Institute of Health (INSA), 1649-016 Lisbon, Portugal. Electronic address: m.joao.simoes@insa.min-saude.pt.
Publikováno v:
Vaccine [Vaccine] 2022 Aug 05; Vol. 40 (33), pp. 4772-4779. Date of Electronic Publication: 2022 Jun 29.
Autor:
García A; GSK, Tres Cantos, Spain. Electronic address: andrea.x.garcia@gsk.com., Vallejo-Aparicio LA; GSK, Tres Cantos, Spain., Begum N; Freelance C/O GSK, Wavre, Belgium., Nikitas G; GSK, Wavre. Belgium., González-Inchausti C; GSK, Tres Cantos, Spain., de Gomensoro E; GSK, Tres Cantos, Spain.
Publikováno v:
Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126155. Date of Electronic Publication: 2024 Aug 14.
Autor:
Ray Borrow, Federico Martinón-Torres, Véronique Abitbol, Anar Andani, Scott Preiss, Alessandro Muzzi, Laura Serino, Woo-Yun Sohn
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 738-748 (2023)
Introduction Neisseria meningitidis serogroup B (NmB) antigens are inherently diverse with variable expression among strains. Prediction of meningococcal B (MenB) vaccine effectiveness therefore requires an assay suitable for use against large panels
Externí odkaz:
https://doaj.org/article/4e1c2a33874d4f68b50c1a9a666b28e7
Autor:
van den Broek B; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands., van der Flier M; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands; Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands., van de Kar NCAJ; Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Wetzels JFM; Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Jonge MI; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands., de Groot R; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands., Wijnsma KL; Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Langereis JD; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands. Electronic address: Jeroen.Langereis@radboudumc.nl.
Publikováno v:
Kidney international [Kidney Int] 2022 Jun; Vol. 101 (6), pp. 1293-1295.
Autor:
Herrera-Restrepo O; GSK, Philadelphia, PA, USA., Clements DE; GSK, Philadelphia, PA, USA., Hebert ZN; Verilogue, Philadelphia, PA, USA., McCracken C; Verilogue, Philadelphia, PA, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2024 Jul; Vol. 40 (7), pp. 1253-1263. Date of Electronic Publication: 2024 Jun 14.
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2024 May; Vol. 30 (5), pp. 1009-1012.